SEC Form 3 · accession 0001493152-18-007676
OncBioMune Pharmaceuticals, Inc · OBMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Neal Holcomb
Director
Period of report
Mar 19, 2018
Accepted (ET)
May 22, 2018 · 5:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001362703
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 6,420,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy) | $0.0135 | holding | — | — | — | May 9, 2018 | May 9, 2018 | Common Stock | 3,000,000 | — | D |
Remarks
Mr. Holcomb was elected as the Company's director on March 19, 2018.